MARKETS

Company Info

QUATERLY RESULTS

Beta Drugs Ltd.

You can view the quaterly results for the last 5 years.

NSE

Oct 22, 02:24

1897.60 +232.90 (+ 13.99%)

Volume 398734

Prev. Close 1664.70

Open Price 1664.70

Today's Low / High

1616.00

1924.00

Bid Price(Qty.) 1898.60 (1)

Open Pr.(Qty.) 1900.00 (1)

52 Wk Low / High

990.10

2807.90

ISIN No	INE351Y01019	Market Cap. ( ₹ in Cr. )	2103.66	P/BV	8.02	Book Value ( ₹ )	236.52
BSE Code	-	52 Week High/Low ( ₹ )	2808/990	FV/ML	10/1	P/E(X)	50.71
NSE Code	BETAEQ	Book Closure	26/03/2025	EPS ( ₹ )	37.42	Div Yield (%)	0.00

(₹ in Crs.)

Particulars	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25
Net Sales/Income from operations	125.55	93.96	87.27	103.39	100.21
Total Income From Operations	125.55	93.96	87.27	103.39	100.21

EXPENDITURE
Consumption of Raw Materials	50.22	36.78	32.50	46.40	58.12
Increase/Decrease in Stocks	4.30	-0.69	3.54	2.90	-8.38
Employees Cost	20.40	18.68	16.82	16.48	2.74
Depreciation	4.35	4.80	4.39	4.24	3.73
Other Expenses	23.27	21.51	17.42	16.30	28.02
Total Expenses	102.53	81.08	74.67	86.32	84.23

P/L Before Other Inc. , Int., Excpt. Items & Tax	23.02	12.88	12.60	17.07	15.98
Other Income	1.58	2.89	2.31	2.99	2.99
P/L Before Interest, Excpt. Items & Tax	24.60	15.78	14.91	20.06	18.97
Interest	2.56	3.94	4.43	3.61	3.32
P/L Before Exceptional Items & Tax	22.04	11.83	10.47	16.44	15.65
P/L Before Tax	22.04	11.83	10.47	16.44	15.65
Tax	5.56	2.78	1.95	4.23	3.95
P/L After Tax from Ordinary Activities	16.49	9.05	8.52	12.22	11.70
Net Profit/Loss For the Period	16.49	9.05	8.52	12.22	11.70
Minority Interest	-0.68	0.00	0.00	0.00	0.00
Net P/L After Minority Interest & Share Of Associates	15.80	9.05	8.52	12.22	11.70

Equity Share Capital	11.09	10.14	10.14	10.09	10.09
EPS Before Extra Ordinary *
Basic EPS (Rs.)	14.78	8.93	8.40	12.10	11.59
Diluted EPS (Rs.)	14.78	8.93	8.40	12.10	11.60
EPS After Extra Ordinary *
Basic EPS (Rs.)	14.78	8.93	8.40	12.10	11.59
Diluted EPS (Rs.)	14.78	8.93	8.40	12.10	11.60

PBITOE Margin (%)	18.33	13.70	14.43	16.50	15.94
PBTE Margin (%)	17.55	12.59	11.99	15.90	15.61
PBT Margin (%)	17.55	12.59	11.99	15.90	15.61
PAT Margin (%)	13.13	9.63	9.75	11.81	11.67
PAT After MI And SOA Margin (%)	12.58	9.63	9.75	11.81	11.67

Particulars	Jun 26
Net Sales/Income from operations	125.55
Total Income From Operations	125.55

EXPENDITURE
Consumption of Raw Materials	50.22
Increase/Decrease in Stocks	4.30
Employees Cost	20.40
Depreciation	4.35
Other Expenses	23.27
Total Expenses	102.53
P/L Before Other Inc. , Int., Excpt. Items & Tax	23.02
Other Income	1.58
P/L Before Interest, Excpt. Items & Tax	24.60
Interest	2.56
P/L Before Exceptional Items & Tax	22.04
P/L Before Tax	22.04
Tax	5.56
P/L After Tax from Ordinary Activities	16.49
Net Profit/Loss For the Period	16.49
Minority Interest	-0.68
Net P/L After Minority Interest & Share Of Associates	15.80
Equity Share Capital	11.09
EPS Before Extra Ordinary *
Basic EPS (Rs.)	14.78
Diluted EPS (Rs.)	14.78
EPS After Extra Ordinary *
Basic EPS (Rs.)	14.78
Diluted EPS (Rs.)	14.78
PBITOE Margin (%)	18.33
PBTE Margin (%)	17.55
PBT Margin (%)	17.55
PAT Margin (%)	13.13
PAT After MI And SOA Margin (%)	12.58

MARKETS

Company Information

QUATERLY RESULTS

Beta Drugs Ltd.

NSE